biopharmaceutical manufacturing
biopharmaceutical manufacturing
2024: The Year of Breakthroughs in Bioprocessing?
Will 2024 be the year of breakthroughs in bioprocessing? 🌟 Find out in this insightful article! Bioprocessing2024
Revolutionary Robotic System Equals Manual Cell Therapy Manufacturing
Automated and manual cell expansion analysis shows statistical equivalence, potentially revolutionizing cell therapy manufacturing. 🤖💉🧬✨💪💊🏥🌟
AGC Invests $350M+ to Build Mammalian Plant in Japan: Boosting Biopharma Manufacturing
💰 AGC, a Japanese pharmaceutical company, plans to invest over $350 million in a new mammalian cell culture plant in Chiba, Japan. 🏭 This plant will produce cell cultures for biopharmaceutical manufacturing, strengthening AGC's position in the market. 🧪 Construction to be completed by 2022.
Accelerating ADC Development and Manufacturing: Streamlining Solutions
📰 ADC Development and Manufacturing: Simplify, Derisk, and Accelerate the Timeline tackles challenges and offers solutions for ADC development and manufacturing. 🧬🔬🎯
Unlocking Biopharma’s Full Potential with IoT
📢 Biopharma industry lags in embracing IoT due to complexity. 🔬 IoT can enhance processes, cut costs. 🏭 Challenges exist. 💡 Sector-wide effort needed. 🌐 Universal solutions, strategies, training can help.
Breaking: Scientists Struggle with Monoclonal Antibody HCPs
📰 Monoclonal Antibody HCP Challenges: Scientists are still facing the challenge of removing host-cell proteins (HCPs) from bioprocesses. ⚗️🔬🧫
Revolutionizing Biopharmaceutical Process Development: Embracing Automation
🔍 Traditional biopharmaceutical process development meets its match with automation! Discover how it's revolutionizing the industry. 🌐📈💊⚙️💡
Revolutionizing Cell & Gene Therapy: Cutting-edge Standards
📢 Polyplus & MarkHerz partner to develop cell & gene therapy standards. Decrease costs, increase quality & exchange knowledge. 💼💡💪
Protein Problems Unlocked: Overcoming Manufacturing Challenges
Unlocking Protein Problems 📅 November 28, 2023 ⚠️ Even promising protein projects can fail due to technical difficulties in manufacturing at a large scale. 👨🔬 Manufacturing expertise is often overlooked but is crucial in avoiding challenges in protein manufacture. 🚀 Conventional solutions like contract manufacturing organizations may fall short in addressing complex protein problems. 🧬 QTL technology enables the resolution of technical challenges in protein projects by optimizing manufacturing strains. 💪 QTL technology has shown its ability to remove roadblocks and make projects viable again.
The Game-Changing Future of Cell and Gene Therapy Relies on Recombinant Albumin
🔬 Stay updated on the future of cell and gene therapy with reliable and affordable recombinant albumin. 🚀 CellTherapy GeneTherapy
